Moderna (MEX:MRNA) Long-Term Capital Lease Obligation : MXN22,790 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Moderna Long-Term Capital Lease Obligation?

Moderna's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was MXN22,790 Mil.

Moderna's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 (MXN20,675 Mil) to Mar. 2024 (MXN20,115 Mil) but then increased from Mar. 2024 (MXN20,115 Mil) to Jun. 2024 (MXN22,790 Mil).

Moderna's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (MXN14,462 Mil) to Dec. 2022 (MXN19,574 Mil) and increased from Dec. 2022 (MXN19,574 Mil) to Dec. 2023 (MXN20,675 Mil).

Moderna Long-Term Capital Lease Obligation Historical Data

The historical data trend for Moderna's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Long-Term Capital Lease Obligation Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2,496.39

4,117.64

14,462.37

19,573.98

20,674.63

Moderna Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															16,235.27	22,156.84	20,674.63	20,114.66	22,790.21

Moderna (MEX:MRNA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Moderna Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Moderna's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil 0QF:Bulgaria MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.